The biology and therapeutic potential of interleukin 27

被引:104
作者
Batten, Marcel
Ghilardi, Nico
机构
[1] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2007年 / 85卷 / 07期
关键词
IL-27; cytokines; T cell;
D O I
10.1007/s00109-007-0164-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Interleukin (IL-) 27 is a helical cytokine of the greater IL-6/IL-12 family with a broad range of pro- and antiinflammatory properties. It can skew T helper cell development, suppress T cell proliferation, stimulate cytotoxic T cell activity, induce isotype switching in B cells, and has diverse effects on innate immune cells. In vivo, its most important role appears to be that of immune regulation, as mice with defects in IL-27 or its receptor display enhanced immune responses in a range of infectious and noninfectious situations. In this review, we discuss the body of knowledge on IL-27 and its potential therapeutic utility.
引用
收藏
页码:661 / 672
页数:12
相关论文
共 86 条
  • [81] WSX-1 is required for the initiation of Th1 responses and resistance to L-major infection
    Yoshida, H
    Hamano, S
    Senaldi, G
    Covey, T
    Faggioni, R
    Mu, S
    Xia, M
    Wakeham, AC
    Nishina, H
    Potter, J
    Saris, CJM
    Mak, TW
    [J]. IMMUNITY, 2001, 15 (04) : 569 - 578
  • [82] Induction of IgG2a class switching in B cells by IL-27
    Yoshimoto, T
    Okada, K
    Morishima, N
    Kamiya, S
    Owaki, T
    Asakawa, M
    Iwakura, Y
    Fukai, F
    Mizuguchi, J
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (04) : 2479 - 2485
  • [83] Two-sided roles of IL-27:: Induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-Induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism
    Yoshimura, Takeru
    Takeda, Atsunobu
    Hamano, Shinjiro
    Miyazaki, Yoshiyuki
    Kinjyo, Ichiko
    Ishibashi, Tatsuro
    Yoshimura, Akihiko
    Yoshida, Hiroki
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (08) : 5377 - 5385
  • [84] Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12
    Yu, WG
    Yamamoto, N
    Takenaka, H
    Mu, J
    Tai, XG
    Zou, JP
    Ogawa, M
    Tsutsui, T
    Wijesuriya, R
    Yoshida, R
    Herrmann, S
    Fujiwara, H
    Hamaoka, T
    [J]. INTERNATIONAL IMMUNOLOGY, 1996, 8 (06) : 855 - 865
  • [85] Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major
    Zahn, S
    Wirtz, S
    Birkenbach, M
    Blumberg, RS
    Neurath, MF
    von Stebut, E
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) : 1106 - 1112
  • [86] SYSTEMIC ADMINISTRATION OF RIL-12 INDUCES COMPLETE TUMOR-REGRESSION AND PROTECTIVE IMMUNITY - RESPONSE IS CORRELATED WITH A STRIKING REVERSAL OF SUPPRESSED IFN-GAMMA PRODUCTION BY ANTITUMOR T-CELLS
    ZOU, JP
    YAMAMOTO, N
    FUJII, T
    TAKENAKA, H
    KOBAYASHI, M
    HERRMANN, SH
    WOLF, SF
    FUJIWARA, H
    HAMAOKA, T
    [J]. INTERNATIONAL IMMUNOLOGY, 1995, 7 (07) : 1135 - 1145